|
Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol 22, No 14S (July 15 Supplement), 2004: 504
© 2004 American Society of Clinical Oncology
MRI detection of multi focal breast carcinoma: Report from the International Breast MRI Consortium
M. D. Schnall,
J. Blume,
D. Bluemke,
S. Smazal,
G. Deangelis,
S. Harms,
C. Kuhl,
N. Hylton and
C. Gatsonis International Breast MRI Consortium
University of Pennsylvania, Philadelphia, PA; Brown University, Providence, RI; Johns Hopkins, Baltimore, MD; Porter Care Adventist Hospital, Denver, CO; University of Virginia, Charlottesville, VA; University of Arkansas, Little Rock, AR; University of Bonn, Bonn, Germany; UCSF, San Francisco, CA
504
Background: Prior single institution studies suggest MRI may improve the assessment of the extent of cancer within the breast, and thus reduce the risk of leaving macroscopic disease in the breast following breast conservation. We report on the rate of MRI and mammography detection of multi-focal breast cancer in a prospective, multi center trial. Methods: 1004 women with suspicious mammographic and/or clinical findings were enrolled into IBMC 6883 at 17 institutions in the US, Canada and Germany. Women underwent mammography and MRI prior to biopsy of the suspicious index lesion. In addition to characterizing the index lesion, additional incidental lesions (IL) detected by mammography and MRI were noted and characterized. An IL was defined as a finding separated from the index lesion by at least 2 cm. All index lesions and suspicious ILs were recommended for biopsy. Results: 428 of 1004 (43%) women had an index lesion diagnosis of cancer. Of these 428 women, MRI detected at least 1 suspicious IL in 103 (24%) women, while mammography detected at least 1 suspicious IL in 36 (8%) women. Pathology was available for at least 1 MRI detected IL in 78, and at least 1 mammography detected IL in 20 women. Results are illustrated below:
Conclusions: MRI has a significantly higher yield than mammography in detecting multi-focal disease in women with breast cancer. The biopsy yields of mammography and MRI are similar in this patient population.
Author Disclosure
| Employment or Leadership |
Consultant or Advisory |
Stock Ownership |
Honoraria |
Research Funding |
Expert Testimony |
Other Remuneration |
|
| Aurora Technologies |
Aroura Technologies |
Aroura Technologies |
|
|
|
|
|
Abstract presentation from the 2004 ASCO Annual Meeting
|